Butyrylcholinesterase for protection from organophosphorus poisons: Catalytic complexities and hysteretic behavior
Open accessAbstract
Butyrylcholinesterase is a promiscuous enzyme that displays complex kinetic behavior. It is toxicologically important because it detoxifies organophosphorus poisons (OP) by making a covalent bond with the OP. The OP and the butyrylcholinesterase are both inactivated in the process. Inactivation of butyrylcholinesterase has no adverse effects. However, inactivation of acetylcholinesterase in nerve synapses can be lethal. OP-inhibited butyrylcholinesterase and acetylcholinesterase can be reactivated with oximes provided the OP has not aged. Strategies for preventing the toxicity of OP include (a) treatment with an OP scavenger, (b) reaction of non-aged enzyme with oximes, (c) reactivation of aged enzyme, (d) slowing down aging with peripheral site ligands, and (e) design of mutants that rapidly hydrolyze OP. Option (a) has progressed through phase I clinical trials with human butyrylcholinesterase. Option (b) is in routine clinical use. The others are at the basic research level. Butyrylcholinesterase displays complex kinetic behavior including activation by positively charged esters, ability to hydrolyze amides, and a lag time (hysteresis) preceding hydrolysis of benzoylcholine and N-methylindoxyl acetate. Mass spectrometry has identified new OP binding motifs on tyrosine and lysine in proteins that have no active site serine. It is proposed, but not yet proven, that low dose exposure involves OP modification of proteins that have no active site serine.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increasing acetylcholine concentration at the synapse by inhibiting AChE is one approach to slow down the progression of AD.
“An increase of acetylcholine concentration (ACh) at the synapse by inhibiting the acetylcholinesterase (AChE) is one of the approaches to slow down the progression of AD [18,19,20,21,22,23,24,25,26].”
From Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991) · Science · doi:10.1126/science.1678899 · Cited by 2,711 · see citing works
Management of acute organophosphorus pesticide poisoning
Eddleston, M., Buckley, N. A., Eyer, P., & Dawson, A. H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61202-1 · Cited by 1,189 · see citing works
Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states
Quinn, D. M. (1987) · Chemical Reviews · doi:10.1021/cr00081a005 · Cited by 1,072 · see citing works
Neurobiology of butyrylcholinesterase
Darvesh, S., Hopkins, D. A., & Geula, C. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1035 · Cited by 896 · see citing works
Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products
Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J. C., & Nachon, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210241200 · Cited by 851 · see citing works
Kinetic Aspects of Regulation of Metabolic Processes
Frieden, C. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62721-8 · Cited by 627 · see citing works
Li, B., Sedlacek, M., Manoharan, I., Boopathy, R., Duysen, E. G., Masson, P., & Lockridge, O. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.002 · Cited by 542 · see citing works
Organophosphate Toxicology: Safety Aspects of Nonacetylcholinesterase Secondary Targets
Casida, J. E., & Quistad, G. B. (2004) · Chemical Research in Toxicology · doi:10.1021/tx0499259 · Cited by 526 · see citing works
Handbook of Toxicology of Chemical Warfare Agents
Gupta, R. C. (2015) · Elsevier eBooks · doi:10.1016/c2013-0-15402-5 · Cited by 475 · see citing works
Axonal Transport Defects in Neurodegenerative Diseases
Morfini, G. A., Burns, M. R., Binder, L. I., Kanaan, N. M., LaPointe, N. E., Bosco, D. A., Brown, R. H., Brown, H. E., Tiwari, A., Hayward, L. J., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3463-09.2009 · Cited by 464 · see citing works
Radić, Z., Pickering, N. A., Vellom, D. C., Camp, S., & Taylor, P. (1993) · Biochemistry · doi:10.1021/bi00096a018 · Cited by 437 · see citing works
Cholinesterases and Anticholinesterase Agents
Koelle, G. B. (1963) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-99875-1 · Cited by 417 · see citing works
Newcomb, R. D., Campbell, P. M., Ollis, D. L., Cheah, E., Russell, R. J., & Oakeshott, J. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7464 · Cited by 378 · see citing works
Human Carboxylesterase Isozymes: Catalytic Properties and Rational Drug Design
Imai, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.173 · Cited by 359 · see citing works
Sarin experiences in Japan: Acute toxicity and long-term effects
Yanagisawa, N., Morita, H., & Nakajima, T. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.06.007 · Cited by 332 · see citing works
Handbook of Toxicology of Chemical Warfare Agents
Gupta, R. C. 1. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374484-5.x0001-6 · Cited by 308 · see citing works
Pesticide exposure and risk of Parkinson's disease: A family-based case-control study
Hancock, D. B., Martin, E. R., Mayhew, G. M., Stajich, J. M., Jewett, R. M., Stacy, M. A., Scott, B. L., Vance, J. M., & Scott, W. K. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-6 · Cited by 285 · see citing works
Inaba, T., Stewart, D. J., & KALOW, W. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978235547 · Cited by 254 · see citing works
Plasma cholinesterase variants and the anaesthetist
Whittaker, M. (1980) · Anaesthesia · doi:10.1111/j.1365-2044.1980.tb03800.x · Cited by 238 · see citing works
Advances in laboratory evolution of enzymes.
Bershtein, S., & Tawfik, D. S. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.027 · Cited by 219 · see citing works
Fidder, A., Hulst, A. G., Noort, D., de Ruiter, R., van der Schans, M. J., Benschop, H. P., & Langenberg, J. P. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0101806 · Cited by 216 · see citing works
Acetylcholinesterase inhibitors and Gulf War illnesses
Golomb, B. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711986105 · Cited by 216 · see citing works
Huang, Y., Huang, Y., Baldassarre, H., Wang, B., Lazaris, A., Leduc, M., Bilodeau, A. S., Bellemare, A., Côté, M., Herskovits, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702756104 · Cited by 214 · see citing works
Polhuijs, M., Langenberg, J. P., & Benschop, H. P. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8243 · Cited by 213 · see citing works
Keynote review: Mammalian carboxylesterases: From drug targets to protein therapeutics
Redinbo, M. R., & Potter, P. M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03383-0 · Cited by 213 · see citing works
Jokanović, M., & Prostran, M. S. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788612729 · Cited by 190 · see citing works
Computational redesign of human butyrylcholinesterase for anticocaine medication
Pan, Y., Gao, D., Yang, W., Cho, H., Yang, G., Tai, H., & Zhan, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507332102 · Cited by 185 · see citing works
Barr, D. B., Allen, R. H., Olsson, A. O., Bravo, R., Caltabiano, L. M., Montesano, M. A., Nguyen, J. V., Udunka, S. O., Walden, D., Walker, R. D., et al. (2005) · Environmental Research · doi:10.1016/j.envres.2005.03.012 · Cited by 177 · see citing works
Most Efficient Cocaine Hydrolase Designed by Virtual Screening of Transition States
Zheng, F., Yang, W., Ko, M., Liu, J., Cho, H., Gao, D., Tong, M., Tai, H., Woods, J. H., & Zhan, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803646t · Cited by 176 · see citing works
Avigdor Shafferman, C., Ordentlich, A., Barak, D., Stein, D., Ariel, N., & Velan, B. (1996) · Biochemical Journal · doi:10.1042/bj3180833 · Cited by 174 · see citing works
Anatoxin-a(s), an anticholinesterase from the cyanobacterium Anabaena flos-aquae NRC-525-17
Mahmood, N. A., & Carmichael, W. W. (1987) · Toxicon · doi:10.1016/0041-0101(87)90140-1 · Cited by 171 · see citing works
Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics
Worek, F., Diepold, C., & Eyer, P. (1999) · Archives of Toxicology · doi:10.1007/s002040050580 · Cited by 167 · see citing works
Lockridge, O., Blong, R. M., Masson, P., Froment, M.-T., Millard, C. B., & Broomfield, C. A. (1997) · Biochemistry · doi:10.1021/bi961412g · Cited by 162 · see citing works
Albumin, a New Biomarker of Organophosphorus Toxicant Exposure, Identified by Mass Spectrometry
Peeples, E. S. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi023 · Cited by 159 · see citing works
Hartmann, J., Kiewert, C., Duysen, E. G., Lockridge, O., Greig, N. H., & Klein, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04347.x · Cited by 158 · see citing works
Chemical Sensitivity Attributed to Pesticide Exposure versus Remodeling
Miller, C. S., & Mitzel, H. C. (1995) · Archives of Environmental Health An International Journal · doi:10.1080/00039896.1995.9940889 · Cited by 158 · see citing works
Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agents
Williams, N. H., Harrison, J. M., Read, R. W., & Black, R. M. (2007) · Archives of Toxicology · doi:10.1007/s00204-007-0191-8 · Cited by 156 · see citing works
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents
Albuquerque, E. X., Pereira, E. F. R., Aracava, Y., Fawcett, W. P., de Oliveira, M., Randall, W. R., Hamilton, T. A., Kan, R. K., Romano, J. A., & Adler, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605370103 · Cited by 154 · see citing works
Re-engineering Butyrylcholinesterase as a Cocaine Hydrolase
Sun, H., Pang, Y., Lockridge, O., & Brimijoin, S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.220 · Cited by 149 · see citing works
Duysen, E. G., Li, B., Xie, W., Schopfer, L. M., Anderson, R. S., Broomfield, C. A., & Lockridge, O. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29259-4 · Cited by 148 · see citing works
Fundamental Reaction Mechanism for Cocaine Hydrolysis in Human Butyrylcholinesterase
Zhan, C., Zheng, F., & Landry, D. W. (2003) · Journal of the American Chemical Society · doi:10.1021/ja020850+ · Cited by 144 · see citing works
Masson, P., Legrand, P., Bartels, C. F., Froment, M.-T., Schopfer, L. M., & Lockridge, O. (1997) · Biochemistry · doi:10.1021/bi962484a · Cited by 138 · see citing works
The Array Biosensor: Portable, Automated Systems
Ligler, F. S., Sapsford, K. E., Golden, J. P., Shriver‐Lake, L. C., Taitt, C. R., Dyer, M. A., Barone, S., & Myatt, C. J. (2007) · Analytical Sciences · doi:10.2116/analsci.23.5 · Cited by 137 · see citing works
Brimijoin, S., Gao, Y., Anker, J. J., Gliddon, L. A., LaFleur, D. W., Shah, R. R., Zhao, Q., Singh, M., & Carroll, M. E. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301666 · Cited by 137 · see citing works
Wang, H., Wang, J., Timchalk, C. A., & Lin, Y. (2008) · Analytical Chemistry · doi:10.1021/ac801211s · Cited by 136 · see citing works
Human Carboxylesterases: An Update on CES1, CES2 and CES3
Sanghani, S. P., Sanghani, P. C., Schiel, M. A., & BOSRON, W. F. (2009) · Protein and Peptide Letters · doi:10.2174/092986609789071324 · Cited by 135 · see citing works
Ashani, Y., & Pistinner, S. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfh012 · Cited by 133 · see citing works
Xie, W., Altamirano, C. V., Bartels, C. F., Speirs, R. J., Cashman, J. R., & Lockridge, O. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.1.83 · Cited by 130 · see citing works
D’Agostino, P. A., Hancock, J. R., Chenier, C. L., & Lepage, C. R. J. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.01.083 · Cited by 129 · see citing works
Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus
Darvesh, S., & Hopkins, D. A. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10751 · Cited by 128 · see citing works
Ageing and dealkylation of soman (pinacolylmethylphosphonofluoridate)-inactivated eel cholinesterase
Michel, H. O., Hackley, B. E., Berkowitz, L., List, G., Hackley, E. B., Gillilan, W., & Pankau, M. (1967) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(67)90006-9 · Cited by 126 · see citing works
Aging of Cholinesterases Phosphylated by Tabun Proceeds through O-Dealkylation
Carletti, E., Li, H., Li, B., Ekström, F., Nicolet, Y., Loiodice, M., Gillon, É., Froment, M.-T., Lockridge, O., Schopfer, L. M., et al. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804941z · Cited by 126 · see citing works
The kinetics of reactivation, by oximes, of cholinesterase inhibited by organophosphorus compounds
Davies, D. R., & Green, A. L. (1956) · Biochemical Journal · doi:10.1042/bj0630529 · Cited by 124 · see citing works
Manoharan, I., Boopathy, R., Darvesh, S., & Lockridge, O. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.11.005 · Cited by 122 · see citing works
Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?
Maxwell, D. M., Brecht, K. M., Koplovitz, I., & Sweeney, R. E. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0120-2 · Cited by 118 · see citing works
Li, B., Schopfer, L. M., Hinrichs, S. H., Masson, P., & Lockridge, O. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.11.018 · Cited by 116 · see citing works
Binding and Hydrolysis of Soman by Human Serum Albumin
Li, B., Nachon, F., Froment, M.-T., Verdier, L., Debouzy, J. C., Brasme, B., Gillon, É., Schopfer, L. M., Lockridge, O., & Masson, P. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700339m · Cited by 114 · see citing works
Millard, C. B., Lockridge, O., & Broomfield, C. A. (1995) · Biochemistry · doi:10.1021/bi00049a007 · Cited by 113 · see citing works
Lukey, B. J., Romano, J. A., Jr., Romano, J. A., Jr., Salem, H., & Lukey, B. J. (2007) · CRC Press eBooks · doi:10.1201/9781420046625 · Cited by 113 · see citing works
The reactivity of phosphate esters. Reactions of diesters with nucleophiles
Kirby, A. J., & Younas, M. U. (1970) · Journal of the Chemical Society B Physical Organic · doi:10.1039/j29700001165 · Cited by 111 · see citing works
Saxena, A., Redman, A. M. G., Jiang, X., Lockridge, O., & Doctor, B. P. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00014-9 · Cited by 110 · see citing works
Millard, C. B., Lockridge, O., & Broomfield, C. A. (1998) · Biochemistry · doi:10.1021/bi972057c · Cited by 109 · see citing works
Beseler, C. L., Stallones, L. F., Hoppin, J. A., Alavanja, M. C. R., Blair, A. E., Keefe, T. J., & Kamel, F. (2006) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000235938.70212.dd · Cited by 108 · see citing works
The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency
Li, B., Duysen, E. G., Carlson, M., & Lockridge, O. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133330 · Cited by 107 · see citing works
Duysen, E. G., Li, B., Darvesh, S., & Lockridge, O. (2006) · Toxicology · doi:10.1016/j.tox.2006.11.069 · Cited by 102 · see citing works
Nachon, F., Asojo, O. A., Borgstahl, G. E. O., Masson, P., & Lockridge, O. (2005) · Biochemistry · doi:10.1021/bi048238d · Cited by 99 · see citing works
Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers
Li, H., Schopfer, L. M., Masson, P., & Lockridge, O. (2008) · Biochemical Journal · doi:10.1042/bj20071551 · Cited by 95 · see citing works
Detection of metabolites of toxic alkylmethylphosphonates in biological samples
Shih, M. L., Smith, J. R., McMonagle, J. D., Dolzine, T. W., & Gresham, V. C. (1991) · Journal of Mass Spectrometry · doi:10.1002/bms.1200201111 · Cited by 93 · see citing works
Sanson, B., Nachon, F., Colletier, J., Froment, M.-T., Toker, L., Greenblatt, H. M., Sussman, J. L., Ashani, Y., Masson, P., Silman, I., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900433t · Cited by 92 · see citing works
Lockridge, O., Schopfer, L. M., Winger, G. D., et al. (2005) · PubMed · doi:10.1901/jaba.2005.3-nihms5095 · Cited by 91 · see citing works
Self-citationFuture Considerations for the Medical Management of Nerve-Agent Intoxication
Aas, P. (2003) · Prehospital and Disaster Medicine · doi:10.1017/s1049023x00001072 · Cited by 88 · see citing works
Enzymes hydrolysing organophosphorus compounds
Loison, M. G. (1990) · Biochimie · doi:10.1016/0300-9084(90)90180-o · Cited by 86 · see citing works
Structure, Activities and Biomedical Applications of Human Butyrylcholinesterase
Masson, P., Carletti, E., & Nachon, F. (2009) · Protein and Peptide Letters · doi:10.2174/092986609789071207 · Cited by 85 · see citing works
Self-citationBioscavenger for Protection From Toxicity of Organophosphorus Compounds
Saxena, A., Sun, W., Luo, C., Myers, T. M., Koplovitz, I., Lenz, D. E., & Doctor, B. P. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:145 · Cited by 82 · see citing works
Barak, D., Ordentlich, A., Bromberg, A., Kronman, C., Marcus, D., Lazar, A., Ariel, N., Velan, B., & Avigdor Shafferman, C. (1995) · Biochemistry · doi:10.1021/bi00047a008 · Cited by 82 · see citing works
Masson, P., Nachon, F., Broomfield, C. A., Lenz, D. E., Verdier, L., Schopfer, L. M., & Lockridge, O. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.005 · Cited by 81 · see citing works
CHEMICAL REACTIVATION OF PHOSPHORYLATED HUMAN AND BOVINE TRUE CHOLINESTERASES
Hobbiger, F. (1956) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1956.tb01069.x · Cited by 80 · see citing works
Grunwald, J., Marcus, D., Papier, Y., Raveh, L., Pittel, Z., & Ashani, Y. (1997) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(97)01208-6 · Cited by 79 · see citing works
Ekström, F., Åstot, C., & Pang, Y.-P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100151 · Cited by 79 · see citing works
Kronman, C., Velan, B., Gozes, Y., Leitner, M., Flashner, Y., Lazar, A., Marcus, D., Sery, T., Papier, Y., Grosfeld, H., et al. (1992) · Gene · doi:10.1016/0378-1119(92)90134-b · Cited by 78 · see citing works
Grigoryan, H., Schopfer, L. M., Thompson, C. M., Terry, A. V., Masson, P., & Lockridge, O. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.013 · Cited by 78 · see citing works
Noncholinergic functions of cholinesterases
Balasubramanian, A. S., & Bhanumathy, C. D. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.14.8224608 · Cited by 75 · see citing works
Li, H., Schopfer, L. M., Nachon, F., Froment, M.-T., Masson, P., & Lockridge, O. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm215 · Cited by 73 · see citing works
Fleming, C. D., Edwards, C. C., Kirby, S. D., Maxwell, D. M., Potter, P. M., Cerasoli, D. M., & Redinbo, M. R. (2007) · Biochemistry · doi:10.1021/bi700246n · Cited by 72 · see citing works
van der Schans, M. J., Polhuijs, M., Dijk, C. V., Degenhardt, C. E. A. M., Pleijsier, K., Langenberg, J. P., & Benschop, H. P. (2004) · Archives of Toxicology · doi:10.1007/s00204-004-0568-x · Cited by 71 · see citing works
Carletti, E., Aurbek, N., Gillon, É., Loiodice, M., Nicolet, Y., Fontecilla-Camps, J. C., Masson, P., Thiermann, H., Nachon, F., & Worek, F. (2009) · Biochemical Journal · doi:10.1042/bj20090091 · Cited by 69 · see citing works
Masson, P., Froment, M.-T., Bartels, C. F., & Lockridge, O. (1997) · Biochemical Journal · doi:10.1042/bj3250053 · Cited by 66 · see citing works
Mizutani, M., & Itai, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030605g · Cited by 64 · see citing works
Song, Y., & Cooks, R. G. (2007) · Journal of Mass Spectrometry · doi:10.1002/jms.1244 · Cited by 63 · see citing works
Thiermann, H., Szinicz, L., Eyer, P., Felgenhauer, N., Zilker, T. R., & Worek, F. (2006) · Toxicology · doi:10.1016/j.tox.2006.11.056 · Cited by 63 · see citing works
In vitro reactivation and “ageing” of tabun-inhibited blood cholinesterases
Heilbronn, E. (1963) · Biochemical Pharmacology · doi:10.1016/0006-2952(63)90006-6 · Cited by 62 · see citing works
Development of next generation medical countermeasures to nerve agent poisoning
Wetherell, J. R., Price, M. E., Mumford, H., Armstrong, S. J., & Scott, L. (2006) · Toxicology · doi:10.1016/j.tox.2006.07.028 · Cited by 62 · see citing works
Aging of di-isopropyl-phosphorylated human butyrylcholinesterase
Masson, P., Fortier, P.-L., Albaret, C., Froment, M.-T., BARTELS, F. C., & Lockridge, O. (1997) · Biochemical Journal · doi:10.1042/bj3270601 · Cited by 62 · see citing works
Segall, Y., Waysbort, D., Barak, D., Ariel, N., Doctor, B. P., Grunwald, J., & Ashani, Y. (1993) · Biochemistry · doi:10.1021/bi00212a009 · Cited by 60 · see citing works
Free-Energy Perturbation Simulation on Transition States and Redesign of Butyrylcholinesterase
Yang, W., Pan, Y., Zheng, F., Cho, H., Tai, H., & Zhan, C. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.11.051 · Cited by 60 · see citing works
Huang, Y., Lundy, P. M., Lazaris, A., Huang, Y., Baldassarre, H., Wang, B., Turcotte, C., Côté, M., Bellemare, A., Bilodeau, A. S., et al. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-50 · Cited by 60 · see citing works
Dealkylation and Loss of Capacity for Reactivation of Cholinesterase Inhibited by Sarin
Harris, L. W., Fleisher, J. H., Clark, J. H., & Cliff, W. J. (1966) · Science · doi:10.1126/science.154.3747.404 · Cited by 58 · see citing works
Testing of antidotes for organophosphorus compounds: Experimental procedures and clinical reality
Eyer, P., Szinicz, L., Thiermann, H., Worek, F., & Zilker, T. R. (2006) · Toxicology · doi:10.1016/j.tox.2006.08.033 · Cited by 57 · see citing works
Respiratory survival mechanisms in acetylcholinesterase knockout mouse
Chatonnet, F., Boudinot, É., Chatonnet, A., Taysse, L., Daulon, S., Champagnat, J., & Foutz, A. S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02867.x · Cited by 56 · see citing works
A brain detoxifying enzyme for organophosphorus nerve poisons
Nomura, D. K., Leung, D., Chiang, K. P., Quistad, G. B., Cravatt, B. F., & Casida, J. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501915102 · Cited by 56 · see citing works
Jakubowski, E. M., McGuire, J. M., Evans, R. A., Edwards, J. L., Hulet, S. W., Benton, B. J., Forster, J. S., Burnett, D. C., Muse, W. T., Matson, K. L., et al. (2004) · Journal of Analytical Toxicology · doi:10.1093/jat/28.5.357 · Cited by 56 · see citing works
Degradation of acetylcholine in human airways: role of butyrylcholinesterase
Norel, X., Angrisani, M., Labat, C., Gorenne, I., Dulmet, É., Rossi, F., & Brink, C. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13486.x · Cited by 55 · see citing works
Enzymes hydrolysing organophosphorus compounds
Reiner, E., Aldridge, W. N., & HOSKIN, F. C. G. (1989) · E. Horwood eBooks · Cited by 53 · see citing works
Masson, P., Clery, C., Guerra, P., REDSLOB, A., Albaret, C., & Fortier, P.-L. (1999) · Biochemical Journal · doi:10.1042/bj3430361 · Cited by 52 · see citing works
Model of Human Butyrylcholinesterase Tetramer by Homology Modeling and Dynamics Simulation
Pan, Y., Muzyka, J. L., & Zhan, C. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp8114995 · Cited by 48 · see citing works
Mass spectral characterization of organophosphate-labeled lysine in peptides
Grigoryan, H., Li, B., Xue, W., Grigoryan, M., Schopfer, L. M., & Lockridge, O. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.07.008 · Cited by 48 · see citing works
Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning
Saxena, A., Maxwell, D. M., Quinn, D. M., Radić, Z., Taylor, P., & Doctor, B. P. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00180-9 · Cited by 48 · see citing works
Johnson, J. L., Cusack, B. M., Hughes, T. F., McCullough, E. H., Fauq, A. H., Romanovskis, P., Spatola, A. F., & Rosenberry, T. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304797200 · Cited by 48 · see citing works
Zheng, F., & Zhan, C. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b716268e · Cited by 48 · see citing works
Carbofuran poisoning detected by mass spectrometry of butyrylcholinesterase adduct in human serum
Li, H., Ricordel, I., Tong, Y., Schopfer, L. M., Baud, F. J., Mégarbane, B., Maury, É., Masson, P., & Lockridge, O. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1392 · Cited by 46 · see citing works
The Role of Glutamate-199 in the Aging of Cholinesterase
Saxena, A., Doctor, B. P., Maxwell, D. M., Lenz, D. E., Radić, Z., & Taylor, P. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2481 · Cited by 46 · see citing works
Behrman, E. J., Biallas, M. J., Brass, H. J., Edwards, J. O., & Isaks, M. (1970) · The Journal of Organic Chemistry · doi:10.1021/jo00834a044 · Cited by 44 · see citing works
Differential protein adduction by seven organophosphorus pesticides in both brain and thymus
Carter, W. G., Tarhoni, M. H., Rathbone, A., & Ray, D. E. (2007) · Human & Experimental Toxicology · doi:10.1177/0960327107074617 · Cited by 44 · see citing works
Damped oscillatory hysteretic behaviour of butyrylcholinesterase with benzoylcholine as substrate
Masson, P., Goldstein, B. N., Debouzy, J. C., Froment, M.-T., Lockridge, O., & Schopfer, L. M. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03924.x · Cited by 42 · see citing works
Tahmaz, N., Soutar, A., & Cherrie, J. W. (2003) · The Annals of Occupational Hygiene · doi:10.1093/annhyg/meg042 · Cited by 42 · see citing works
Reactions of phosphonic acid esters with nucleophiles. I. Hydrolysis
Behrman, E. J., Biallas, M. J., Brass, H. J., Edwards, J. O., & Isaks, M. (1970) · The Journal of Organic Chemistry · doi:10.1021/jo00834a043 · Cited by 41 · see citing works
Berman, H. A., & Decker, M. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67434-4 · Cited by 40 · see citing works
Grigoryan, H., Li, B., Anderson, E. K., Xue, W., Nachon, F., Lockridge, O., & Schopfer, L. M. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.03.018 · Cited by 40 · see citing works
Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates
Kovarik, Z., Radić, Z., Berman, H. A., & Taylor, P. (2006) · Toxicology · doi:10.1016/j.tox.2006.08.032 · Cited by 38 · see citing works
Masson, P., & Goasdoue, J.-L. (1986) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(86)90070-1 · Cited by 37 · see citing works
Unique Push−Pull Mechanism of Dealkylation in Soman-Inhibited Cholinesterases
Viragh, C., Akhmetshin, R. R., Kovach, I. M., & Broomfield, C. A. (1997) · Biochemistry · doi:10.1021/bi962764q · Cited by 36 · see citing works
Role of butyrylcholinesterase in canine tracheal smooth muscle function
Adler, M., & Filbert, M. G. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80300-8 · Cited by 36 · see citing works
Photoreversible Inhibition of Cholinesterases: Catalytic Serine‐Labeled Caged Butyrylcholinesterase
Loudwig, S., Nicolet, Y., Masson, P., Fontecilla-Camps, J. C., Bon, S., Nachon, F., & Goeldner, M. P. (2003) · ChemBioChem · doi:10.1002/cbic.200300571 · Cited by 36 · see citing works
Wang, Y. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.018 · Cited by 35 · see citing works
Dorandeu, F., Foquin, A., Briot, R., Delacour, C., Denis, J., Alonso, A., Froment, M.-T., Renault, F., Lallement, G., & Masson, P. (2008) · Toxicology · doi:10.1016/j.tox.2008.03.013 · Cited by 35 · see citing works
Masson, P., Froment, M.-T., Fort, S., Ribes, F., Bec, N., Balny, C., & Schopfer, L. M. (2002) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(02)00265-0 · Cited by 34 · see citing works
Developing procedures for the large-scale purification of human serum butyrylcholinesterase
Saxena, A., Luo, C., & Doctor, B. P. (2008) · Protein Expression and Purification · doi:10.1016/j.pep.2008.05.021 · Cited by 34 · see citing works
Poyot, T., Nachon, F., Froment, M.-T., Loiodice, M., Wieseler, S., Schopfer, L. M., Lockridge, O., & Masson, P. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.07.008 · Cited by 33 · see citing works
Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides
Masson, P., Froment, M.-T., Gillon, É., Nachon, F., Darvesh, S., & Schopfer, L. M. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.06.004 · Cited by 33 · see citing works
Schallreuter, K. U., Gibbons, N. C. J., Elwary, S. M., Parkin, S. M., & Wood, J. M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.078 · Cited by 32 · see citing works
Li, B., Schopfer, L. M., Grigoryan, H., Thompson, C. M., Hinrichs, S. H., Masson, P., & Lockridge, O. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn211 · Cited by 31 · see citing works
Taylor, P., Kovarik, Z., Reiner, E., & Radić, Z. (2006) · Toxicology · doi:10.1016/j.tox.2006.11.061 · Cited by 30 · see citing works
Aryl acylamidase activity of human serum albumin witho-nitrotrifluoroacetanilide as the substrate
Masson, P., Froment, M.-T., Darvesh, S., Schopfer, L. M., & Lockridge, O. (2007) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701383932 · Cited by 29 · see citing works
Effect of histidine modification on the aging of organophosphate-inhibited acetylcholinesterase
Beauregard, G., Lum, J., & Roufogalis, B. D. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90252-5 · Cited by 29 · see citing works
Nomura, D. K., Fujioka, K., Issa, R. S., Ward, A. M., Cravatt, B. F., & Casida, J. E. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.11.021 · Cited by 28 · see citing works
Amitai, G., Ashani, Y., Gafni, A., & Silman, I. (1982) · Biochemistry · doi:10.1021/bi00538a013 · Cited by 28 · see citing works
Pressure and Propylene Carbonate Denaturation of Native and "Aged" Phosphorylated Cholinesterase
Masson, P., Gouet, P., & Clery, C. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1305 · Cited by 28 · see citing works
Epstein, T. M., Samanta, U., Kirby, S. D., Cerasoli, D. M., & Bahnson, B. J. (2009) · Biochemistry · doi:10.1021/bi8023527 · Cited by 28 · see citing works
Sweeney, R. E., & Maxwell, D. M. (2003) · Mathematical Biosciences · doi:10.1016/s0025-5564(02)00154-2 · Cited by 27 · see citing works
Refined crystal structures of “aged” and “non-aged” organophosphoryl conjugates of γ-chymotrypsin
Harel, M., Su, C.-T., Frolow, F., Ashani, Y., Silman, I., & Sussman, J. L. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80183-u · Cited by 27 · see citing works
Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics
Masson, P., Schopfer, L. M., Froment, M.-T., Debouzy, J. C., Nachon, F., Gillon, É., Lockridge, O., Hrabovská, A., & Goldstein, B. N. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.10.019 · Cited by 26 · see citing works
Aging of soman-inhibited acetylcholinesterase: Inhibitors and accelerators
Schoene, K. (1978) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(78)90243-7 · Cited by 26 · see citing works
Hydrolysis of oxo- and thio-esters by human butyrylcholinesterase
Masson, P., Froment, M.-T., Gillon, É., Nachon, F., Lockridge, O., & Schopfer, L. M. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.10.012 · Cited by 25 · see citing works
Kovach, I. M. (2004) · Journal of Physical Organic Chemistry · doi:10.1002/poc.778 · Cited by 25 · see citing works
Ashani, Y., Gentry, M. K., & Doctor, B. P. (1990) · Biochemistry · doi:10.1021/bi00462a004 · Cited by 25 · see citing works
Tacrine slows the rate of ageing of sarin-inhibited acetylcholinesterase
Dawson, R. M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90689-7 · Cited by 24 · see citing works
Cholinesterases in cardiac ganglia and modulation of canine intrinsic cardiac neuronal activity
Darvesh, S., Macdonald, S. E., Losier, A. M., Martin, E. V., Hopkins, D. A., & Armour, J. A. (1998) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(98)00064-2 · Cited by 24 · see citing works
The structure of G117H mutant of butyrylcholinesterase: Nerve agents scavenger
Amitay, M., & Shurki, A. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22442 · Cited by 24 · see citing works
Masson, P., Froment, M.-T., Gillon, É., Nachon, F., Lockridge, O., & Schopfer, L. M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06409.x · Cited by 23 · see citing works
Small Molecular Products of Dealkylation in Soman-Inhibited Electric Eel Acetylcholinesterase
Viragh, C., Kovach, I. M., & Pannell, L. K. (1999) · Biochemistry · doi:10.1021/bi991112+ · Cited by 22 · see citing works
Mazor, O., Cohen, O., Kronman, C., Raveh, L., Stein, D., Ordentlich, A., & Avigdor Shafferman, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047449 · Cited by 22 · see citing works
Wetherell, J. R., & French, M. C. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90080-8 · Cited by 20 · see citing works
Purification and properties of soman-hydrolyzing enzyme from human liver
Wang, Q., Sun, M.-J., Zhang, H., & Huang, C. (1998) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(1998)12:4 · Cited by 20 · see citing works
Aged and non-aged pyrenebutyl-containing organophosphoryl conjugates of chymotrypsin
Grunwald, J., Segall, Y., Shirin, E., Waysbort, D., Steinberg, N., Silman, I., & Ashani, Y. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90608-4 · Cited by 19 · see citing works
Etude électrophorétique de la butyrylcholinestérase agée après inhibition par le soman
Masson, P., Marnot, B., Lombard, J.-Y., & Morelis, P. (1984) · Biochimie · doi:10.1016/0300-9084(84)90067-1 · Cited by 19 · see citing works
Formation of Nonreactivatible Isopropylmethylphosphonofluoridate-Inhibited Acetylcholinesterase*
Smith, T. E., & Usdin, E. (1966) · Biochemistry · doi:10.1021/bi00873a021 · Cited by 19 · see citing works
A contribution to the mechanism of action of SAD-128
Štalc, A., & Šentjurc, M. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90093-z · Cited by 18 · see citing works
Bolger, M. B., & Taylor, P. (1979) · Biochemistry · doi:10.1021/bi00583a029 · Cited by 17 · see citing works
Zur Frage des Vorkommens von Butyryicholin im Rindergehirn
Henschler, D. (1956) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1956.305.1.97 · Cited by 17 · see citing works
Montenegro, M. F., Moral‐Naranjo, M. T., Muñoz‐Delgado, E., Campoy, F. J., & Vidal, C. J. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06942.x · Cited by 16 · see citing works
Sullivan, J. J., Chen, Y. G., & Goh, K. S. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf070700o · Cited by 13 · see citing works
Rat butyrylcholinesterase‐catalysed hydrolysis of N‐alkyl homologues of benzoylcholine
Hrabovská, A., Debouzy, J. C., Froment, M.-T., Devı́nsky, F., Paulíková, I., & Masson, P. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05144.x · Cited by 13 · see citing works
Gabel, F., Masson, P., Froment, M.-T., Doctor, B. P., Saxena, A., Silman, I., Zaccaı̈, G., & Weik, M. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.10.029 · Cited by 13 · see citing works
Schoene, K., Steinhanses, J., & Wertmann, A. (1980) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(80)90156-4 · Cited by 13 · see citing works
Rush, R. S., Main, A. R., Kilpatrick, B. F., & Faulkner, G. D. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32469-9 · Cited by 13 · see citing works
Ketamine protects acetylcholinesterase against in vitro inhibition by sarin
Puu, G. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90191-8 · Cited by 12 · see citing works
DAWSON, R., DOWLING, M., & Poretski, M. (1991) · Neurochemistry International · doi:10.1016/0197-0186(91)90127-y · Cited by 11 · see citing works
Pattison, S. E., & Bernhard, S. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3613 · Cited by 11 · see citing works
Human butyrylcholinesterase components differ in aryl acylamidase activity
Montenegro, M. F., Moral‐Naranjo, M. T., de la Cadena, M. P., Campoy, F. J., Muñoz‐Delgado, E., & Vidal, C. J. (2008) · Biological Chemistry · doi:10.1515/bc.2008.041 · Cited by 11 · see citing works
Hysteresis of insect acetylcholinesterase
Badiou, A., Froment, M.-T., Fournier, D. D., Masson, P., & Belzunces, L. P. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.05.039 · Cited by 10 · see citing works
Cashman, J. R., Berkman, C. E., Underiner, G. E., Kolly, C. A., & Hunter, A. D. (1998) · Chemical Research in Toxicology · doi:10.1021/tx9800203 · Cited by 10 · see citing works
Rajesh, R. V., Loganathan, C., Layer, P. G., & Boopathy, R. (2009) · Biochimie · doi:10.1016/j.biochi.2009.07.004 · Cited by 8 · see citing works
Transient Kinetics of the Acetylcholinesterase Catalyzed Hydrolysis of N-Methylindoxyl Acetate
Sadar, M. H., & Laidler, K. J. (1975) · Canadian Journal of Biochemistry · doi:10.1139/o75-052 · Cited by 6 · see citing works
Identification of Unknown Quaternary Ammonium Compounds in Corneal Epithelium and Aqueous Humor
Reubsaet, L., & Ringvold, A. (2005) · Journal of Chromatographic Science · doi:10.1093/chromsci/43.8.401 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- [124]Lenz DE Broomfield CA Yeung DT Masson P Maxwell DM Cerasoli DM Romano JA Lukey BJ Salem H Chemical Warfare Agents Chemistry, Pharmacology, Toxicology and Therapeutics CRC Press Boca Raton, FL 2007 175 202
- [135]Schopfer LM Ticu-Boeck A Broomfield CA Lockridge O J Med Chem Def online journal 2 2004 1 21
- [139]Masson P Rochu D Gupta RC Handbook of Toxicology of Chemical Warfare Agents Elsevier-Academic Press Amsterdam 2009 1053 1065
- [164]Schopfer LM Grigoryan H Li B Masson P Lockridge O J Chromatography B in press 2009
- [177]Li B Schopfer LM Hinrichs SH Masson P Lockridge O Anal Biochem 361 2007 263 272 17188226 PMC1828685
- [178]Williams NH Harrison JM Read RW Black RM Arch Toxicol 81 2007 627 639 17345062
- [179]Li B Nachon F Froment MT Verdier L Debouzy JC Brasme B Gillon E Schopfer LM Lockridge O Masson P Chem Res Toxicol 21 2008 421 431 18163544
- [181]Seto Y Gupta RC Handbook of Toxicology of Chemical Warfare Agents Academic Press 2009 Chapter 53 813 825
Cited by
Sorted by citations
Songa, E. A., & Okonkwo, J. O. (2016) · Talanta · doi:10.1016/j.talanta.2016.04.046 · Cited by 373 · see citing works
A molecular approach in drug development for Alzheimer’s disease
Agatonović-Kuštrin, S., Kettle, C., & Morton, D. W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.147 · Cited by 236 · see citing works
Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity
Terekhov, S. S., Smirnov, I. V., Stepanova, A. V., Bobik, T. V., Mokrushina, Y. A., Ponomarenko, N. A., Belogurov, A. A., Rubtsova, M. P., Kartseva, O. V., Gomzikova, M. O., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621226114 · Cited by 224 · see citing works
Progress in the development of enzyme-based nerve agent bioscavengers
Nachon, F., Brazzolotto, X., Trovaslet, M., & Masson, P. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.06.012 · Cited by 166 · see citing works
“More than 60 mutants of hBChE and hAChE were created by inserting a second nucleophile in the active center (for reviews see: [63,64]).”
BackgroundXing, S., Li, Q., Xiong, B., Chen, Y., Feng, F., Liu, W., & Sun, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21745 · Cited by 126 · see citing works
“(B) The surface view of active site of huAChE.”
BackgroundInfluentialA Comprehensive Review of Cholinesterase Modeling and Simulation
Boer, D. D., Nguyen, N. M., Mao, J., Moore, J., & Sorin, E. J. (2021) · Biomolecules · doi:10.3390/biom11040580 · Cited by 114 · see citing works
Arya, A., Chahal, R., Rao, R., Rahman, M. H., Kaushik, D., Akhtar, M. F., Saleem, A., Khalifa, S. M. A., El-Seedi, H. R., Kamel, M., et al. (2021) · Biomolecules · doi:10.3390/biom11030350 · Cited by 111 · see citing works
Li, Q., Xing, S., Chen, Y., Liao, Q., Xiong, B., He, S., Lu, W., Liu, Y., Yang, H., Li, Q., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01129 · Cited by 106 · see citing works
Masson, P., & Lushchekina, S. V. (2022) · Molecules · doi:10.3390/molecules27206861 · Cited by 105 · see citing works
Evolution of and perspectives on therapeutic approaches to nerve agent poisoning
Masson, P. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.04.006 · Cited by 93 · see citing works
Organophosphorus Xenobiotic Toxicology
Casida, J. E. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104926 · Cited by 92 · see citing works
Johnson, G., & Moore, S. W. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.016 · Cited by 91 · see citing works
“Surgery, Faculty of Health ygerberg 7505, South Africa. levels in the body actually exceed those of AChE in all tissues except muscle and brain (Li et al., 2000), and also that the enzyme functions as a detoxifier (review: Masson and Lockridge, 2010).”
Radić, Z., Dale, T. J., Kovarik, Z., Berend, S., Garcia, E. S., Zhang, L., Amitai, G., Green, C., Radić, B., Duggan, B. M., et al. (2012) · Biochemical Journal · doi:10.1042/bj20121612 · Cited by 87 · see citing works
Du, D., Wang, J., Wang, L., Lu, D., Smith, J. N., Timchalk, C. A., & Lin, Y. (2011) · Analytical Chemistry · doi:10.1021/ac200217d · Cited by 84 · see citing works
Structural approach to the aging of phosphylated cholinesterases
Masson, P., Nachon, F., & Lockridge, O. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.03.027 · Cited by 81 · see citing works
Geyer, B. C., Kannan, L. S., Garnaud, P.-E., Broomfield, C. A., Cadieux, C. L., Cherni, I., Hodgins, S. M., Kasten, S. A., Kelley, K., Kilbourne, J. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009021107 · Cited by 81 · see citing works
“Studies using plasma-derived human BChE (hBChE) provided proof of concept (21), but also raised concerns over the limited availability of hBChE, and the risk inherent to the use of a human blood product.”
BackgroundQuantitative butyrylcholinesterase activity detection by surface-enhanced Raman spectroscopy
Nechaeva, N. L., Prokopkina, T., Махаева, Г. Ф., Рудакова, Е. В., Boltneva, N. P., Dishovsky, C., Eremenko, A. V., & Kurochkin, I. N. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.11.174 · Cited by 73 · see citing works
Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects
Махаева, Г. Ф., Radchenko, E. V., Palyulin, V. A., Рудакова, Е. В., Aksinenko, A. Y., Sokolov, V. B., Zefirov, N. S., & Richardson, R. J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.10.012 · Cited by 72 · see citing works
The progress in the cholinesterase quantification methods
Holas, O., Musílek, K., Pohanka, M., & Kuča, K. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.729037 · Cited by 70 · see citing works
“BChE may be found in the liver, blood serum, and kidney [6,7].”
BackgroundEsterase profiles of organophosphorus compounds in vitro predict their behavior in vivo
Махаева, Г. Ф., Рудакова, Е. В., Serebryakova, O. G., Aksinenko, A. Y., Lushchekina, S. V., Бачурин, С. О., & Richardson, R. J. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.002 · Cited by 68 · see citing works
Zhang, X., Wang, H., Yang, C., Du, D., & Lin, Y. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.09.047 · Cited by 67 · see citing works
“Since the average concentration of BChE in human plasma is 40–70 nM (Bartels et al., 2000; Jun et al., 2009; Masson and Lockridge, 2010), this method is sensitive enough to detect 0.01 nM OP-BChE, which is less than 1% BChE inhibition.”
MethodInfluentialDarreh-Shori, T., Forsberg, A., Modiri, N., Andreasen, N., Blennow, K., Kamil, C., Ahmed, H., Almkvist, O., Långström, B., & Nordberg, A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.028 · Cited by 64 · see citing works
Kang, J. S., Lee, D., Koh, Y. H., & Lee, S. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019063 · Cited by 65 · see citing works
“The BuChE is known to have several functions, including a backup for AChE, an auxiliary role in development and a protective function in detoxifying orally ingested toxic compounds [27,28,29].”
Petrov, K. A., Girard, E., Nikitashina, A. D., Colasante, C., Bernard, V., Faritovich, N. L., Leroy, J., Samigullin, D. V., Colak, O., Nikolsky, E., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0329-14.2014 · Cited by 65 · see citing works
Biomarkers of organophosphorus (OP) exposures in humans
Marsillach, J., Richter, R. J., Kim, J. H., Stevens, R. C., MacCoss, M. J., Tomazela, D. M., Suzuki, S. M., Schopfer, L. M., Lockridge, O., & Furlong, C. E. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.06.005 · Cited by 64 · see citing works
“BChE can play an important role in the detoxification of ingested or inhaled OPs by stoichiometrically binding OP molecules (Masson and Lockridge, 2010).”
BackgroundCholinesterases in Biorecognition and Biosensors Construction: A Review
Pohanka, M. (2013) · Analytical Letters · doi:10.1080/00032719.2013.780240 · Cited by 63 · see citing works
“It is noteworthy that most of irreversible inhibitors inhibit both AChE and BChE while number of AChE reversible inhibitors does not affect BChE activity (Pohanka 2012b; Masson and Lockridge 2010; Pohanka 2011).”
BackgroundButyrylcholinesterase as a biochemical marker
Pohanka, M. (2013) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2013_153 · Cited by 61 · see citing works
Ge, X., Zhang, W., Lin, Y., & Du, D. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.07.017 · Cited by 59 · see citing works
Pezzementi, L., Nachon, F., & Chatonnet, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017396 · Cited by 57 · see citing works
“By contrast, the larger gorge and increased sensitivity to some inhibitors allows BChE to act as a stoichiometric scavenger of natural and man-made carbamate and organophosphate inhibitors [2].”
BackgroundDetection of Adduct on Tyrosine 411 of Albumin in Humans Poisoned by Dichlorvos
Li, B., Ricordel, I., Schopfer, L. M., Baud, F. J., Mégarbane, B., Nachon, F., Masson, P., & Lockridge, O. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq117 · Cited by 57 · see citing works
“(2) Spontaneous dealkylation of the OP on BChE occurs via the aging process (Masson and Lockridge, 2010).”
BackgroundMasson, P., Lushchekina, S. V., Schopfer, L. M., & Lockridge, O. (2013) · Biochemical Journal · doi:10.1042/bj20130389 · Cited by 57 · see citing works
Interactions of cyclodextrins and their derivatives with toxic organophosphorus compounds
Letort, S., Balieu, S., Erb, W., Gouhier, G., & Estour, F. (2016) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.12.23 · Cited by 56 · see citing works
Wandhammer, M., Carletti, E., van der Schans, M., Gillon, É., Nicolet, Y., Masson, P., Goeldner, M. P., Noort, D., & Nachon, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209569 · Cited by 55 · see citing works
Catalytic bioscavengers as countermeasures against organophosphate nerve agents
Goldsmith, M., & Ashani, Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.006 · Cited by 53 · see citing works
Butyrylcholinesterase activity in multiple sclerosis neuropathology
Darvesh, S., LeBlanc, A. M., Macdonald, I. R., Reid, G. A., Bhan, V., Macaulay, R. J. B., & Fisk, J. D. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.01.037 · Cited by 49 · see citing works
Kovarik, Z., Hrvat, N. M., Katalinić, M., Sit, R. K., Paradyse, A. R., Žunec, S., Musílek, K., Fokin, V. V., Taylor, P., & Radić, Z. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00060 · Cited by 46 · see citing works
Liu, L., Koo, Y., Russell, T. A., Gay, E. A., Li, Y., & Yun, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230335 · Cited by 45 · see citing works
Parikh, K., Duysen, E. G., Snow, B., Jensen, N. S., Manne, V., Lockridge, O., & Chilukuri, N. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175646 · Cited by 44 · see citing works
“8) is universal in tissue distribution (Masson and Lockridge, 2010) and is a major constituent of plasma (Ryhänen, 1983).”
BackgroundEmerging significance of butyrylcholinesterase
Sridhar, G. R., & Gumpeny, L. (2024) · World Journal of Experimental Medicine · doi:10.5493/wjem.v14.i1.87202 · Cited by 43 · see citing works
Current approaches to enhancing oxime reactivator delivery into the brain
Kobrlová, T., Korábečný, J., & Soukup, O. (2019) · Toxicology · doi:10.1016/j.tox.2019.05.006 · Cited by 43 · see citing works
Delacour, H., Lushchekina, S. V., Mabboux, I., Bousquet, A., Ceppa, F., Schopfer, L. M., Lockridge, O., & Masson, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101552 · Cited by 41 · see citing works
“Though BChE lacks obvious physiological functions, it is of toxicological and pharmacological importance in detoxifying or catabolising ester-containing drugs [1].”
BackgroundVelki, M., & Hackenberger, B. K. (2012) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2012.05.001 · Cited by 41 · see citing works
“, acetylcholinesterase (AChE), butyrylcholinesterase (BChE), neuropathy target esterase (NTE) and carboxylesterase (CES) (Fukuto, 1990; Wheelock et al., 2005; Masson and Lockridge, 2010; Satoh and Gupta, 2010).”
BackgroundМахаева, Г. Ф., Radchenko, E. V., Baskin, I. I., Palyulin, V. A., Richardson, R. J., & Zefirov, N. S. (2012) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2012.679690 · Cited by 40 · see citing works
“1) [12,13].”
New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter
Jońca, J., Żuk, M., Wasąg, B., Janaszak‐Jasiecka, A., Lewandowski, K. K., Wielgomas, B., Waleron, K., & Jasiecki, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139480 · Cited by 40 · see citing works
“BChE hydrolyzes chemicals containing ester bonds such as: drugs acting at the neuromuscular junction, local anesthetics like: succinylcholine, mivacurium, procaine [3].”
BackgroundSanchez-Hernandez, J. C., Ríos, J. M., & Attademo, A. M. (2018) · Ecotoxicology · doi:10.1007/s10646-018-1914-8 · Cited by 40 · see citing works
“molecules, therefore leading to their inactivation (Masson and Lockridge 2010; Sogorb and Vilanova 2010).”
BackgroundInfluentialLeung, M. R., van Bezouwen, L. S., Schopfer, L. M., Sussman, J. L., Silman, I., Lockridge, O., & Zeev‐Ben‐Mordehai, T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817009115 · Cited by 40 · see citing works
“Because of its ability to hydrolyze organophosphates (OPs), such as nerve agents and pesticides (3), and drugs such as cocaine (7, 8) and heroin (9–11), BChE is a promising therapeutic agent with multiple applications.”
BackgroundAcetylcholinesterase: The “Hub” for Neurodegenerative Diseases and Chemical Weapons Convention
Cavalcante, S. F. D. A., Simas, A. B. C., Barcellos, M. C., de Oliveira, V. G. M., Sousa, R. B., Cabral, P. A. M., Kuča, K., & França, T. C. C. (2020) · Biomolecules · doi:10.3390/biom10030414 · Cited by 39 · see citing works
Zandona, A., Katalinić, M., Šinko, G., Kastelić, A. R., Primožič, I., & Kovarik, Z. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02811-5 · Cited by 39 · see citing works
“In that sense, the naturally present plasma butyrylcholinesterase (BChE, EC 3.1.1.8) has been shown to be the most suitable for such studies (Masson and Lockridge 2010; Vučinić et al.”
InfluentialBoyko, K. M., Baymukhametov, T. N., Chesnokov, Y. M., Hons, M., Lushchekina, S. V., Konarev, P. V., Липкин, А. В., Vasiliev, A. L., Masson, P., Popov, V. O., et al. (2018) · Biochimie · doi:10.1016/j.biochi.2018.10.017 · Cited by 38 · see citing works
Pohanka, M. (2013) · Talanta · doi:10.1016/j.talanta.2013.11.045 · Cited by 37 · see citing works
Li, Q., Xiong, B., Wang, Y., Lyu, W., Xing, S., Chen, Y., Liao, Q., He, S., Feng, F., Liu, W., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114510 · Cited by 35 · see citing works
A High-Throughput Diagnostic Method for Measuring Human Exposure to Organophosphorus Nerve Agents
Knaack, J. S., Zhou, Y., Abney, C. W., Jacob, J. T., Prezioso, S. M., Hardy, K., Lemire, S. W., Thomas, J. D., & Johnson, R. C. (2012) · Analytical Chemistry · doi:10.1021/ac302301w · Cited by 36 · see citing works
Human butyrylcholinesterase efficacy against nerve agent exposure
Reed, B. A., Sabourin, C. L. K., & Lenz, D. E. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21886 · Cited by 36 · see citing works
Zhang, Z., Guo, J., Cheng, M., Zhou, W., Wan, Y., Wang, R., Fang, Y., Jin, Y., Liu, J., & Xie, S. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113154 · Cited by 36 · see citing works
The proline‐rich tetramerization peptides in equine serum butyrylcholinesterase
Biberoğlu, K., Schopfer, L. M., Tacal, Ö., & Lockridge, O. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08744.x · Cited by 34 · see citing works
Mumford, H., Price, M. E., Lenz, D. E., & Cerasoli, D. M. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.568944 · Cited by 34 · see citing works
“The concept of use for bioscavengers is that nerve agent would be bound in the blood stream and inactivated prior to reaching target tissues (neuromuscular junction and brain), thus effectively lowering the blood concentration of nerve agent.(3) Butyrylcholinesterase acts as a stoichiometric scavenger: that is, one mo…”
BackgroundVistoli, G., Mazzolari, A., Testa, B., & Pedretti, A. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00121 · Cited by 34 · see citing works
Pashirova, T. N., Salah-Tazdaït, R., Tazdaït, D., & Masson, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147822 · Cited by 33 · see citing works
“( serine-amidases, peptidases, and other proteins) may be Adapted from [112]). responsible for non-cholinergic The concept of bioscavenger and developments of this medical approach in prophylaxis and post-exposure treatment of OP poisoning have been covered in several reviews [151–154].”
BackgroundPeters, J., Martínez, N., Trovaslet, M., Scannapieco, K., Koza, M. M., Masson, P., & Nachon, F. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp00280c · Cited by 33 · see citing works
The first 2 IB ,3 IA -heterodifunctionalized β-cyclodextrin derivatives as artificial enzymes
Letort, S., Mathiron, D., Grel, T., Albaret, C., Daulon, S., Djedaïni‐Pilard, F., Gouhier, G., & Estour, F. (2014) · Chemical Communications · doi:10.1039/c4cc09189b · Cited by 32 · see citing works
Organophosphorus hydrolase as an in vivo catalytic nerve agent bioscavenger
Wales, M. E., & Reeves, T. E. (2012) · Drug Testing and Analysis · doi:10.1002/dta.381 · Cited by 30 · see citing works
Schopfer, L. M., & Lockridge, O. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1325 · Cited by 30 · see citing works
González, V., Huen, K., Venkat, S., Pratt, K., Xiang, P., Harley, K. G., Kogut, K. R., Trujillo, C., Bradman, A., Eskenazi, B., et al. (2012) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/jes.2012.61 · Cited by 30 · see citing works
Functionalized cyclodextrins bearing an alpha nucleophile – A promising way to degrade nerve agents
Estour, F., Letort, S., Müller, S., Kalakuntla, R. K., Provost, R. L., Wille, T., Reiter, G., Worek, F., Lafont, O., & Gouhier, G. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.10.020 · Cited by 29 · see citing works
Tonietto, B. D., Laurentino, A. O. M., Valle, M. T. C., Cestonaro, L. V., Antunes, B. P., Sates, C., dos Santos, N. G., Dallegrave, E., García, S. C., Leal, M. B., et al. (2022) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2022.103924 · Cited by 29 · see citing works
Immunodetection of Serum Albumin Adducts as Biomarkers for Organophosphorus Exposure
Chen, S., Zhang, J., Lumley, L. A., & Cashman, J. R. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201368 · Cited by 29 · see citing works
“The phosphonylated peptide that corresponds to the region surrounding Tyr 411 of HSA shows significant stability, and the adduct is not prone to elimination (Masson and Lockridge, 2010).”
BackgroundMethodCatalytic Bioscavengers: The New Generation of Bioscavenger-Based Medical Countermeasures
Masson, P. (2015) · HAL · Cited by 28 · see citing works
Butyrylcholinesterase–Protein Interactions in Human Serum
Jasiecki, J., Szczoczarz, A., Cysewski, D., Lewandowski, K. C., Skowron, P. M., Waleron, K., & Wasąg, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910662 · Cited by 28 · see citing works
Delacour, H., Lushchekina, S. V., Mabboux, I., Ceppa, F., Masson, P., Schopfer, L. M., & Lockridge, O. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.09.014 · Cited by 27 · see citing works
“importance in detoxifying or catabolising ester-containing drugs [1].”
BackgroundEchidna Venom Gland Transcriptome Provides Insights into the Evolution of Monotreme Venom
Wong, E. S. W., Nicol, S. C., Warren, W. C., & Belov, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079092 · Cited by 27 · see citing works
“The most highly expressed gene in the echidna crural gland is most similar to butyrylcholinesterase, a serine hydrolase, whose physiological function in humans is still unclear, although it has been found to be an effective detoxification enzyme [30,31].”
BackgroundDesign, Synthesis and Bioassays of 3‐Substituted‐3‐Hydroxyoxindoles for Cholinesterase Inhibition
Totobenazara, J., Bacalhau, P., Juan, A. A. S., Marques, C. S., Fernandes, L., Goth, A., Caldeira, A. T., Martins, R., & Burke, A. (2016) · ChemistrySelect · doi:10.1002/slct.201600932 · Cited by 21 · see citing works
Hajimohammadi, S., Lockridge, O., & Masson, P. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1625318 · Cited by 26 · see citing works
Time-dependent kinetic complexities in cholinesterase-catalyzed reactions
Masson, P. (2012) · Biochemistry (Moscow) · doi:10.1134/s0006297912100070 · Cited by 26 · see citing works
Martínez-Morcillo, S., Pérez‐López, M., Míguez, M. P., Valcárcel, Y., & Rodríguez, F. S. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.047 · Cited by 24 · see citing works
Ciepluch, K., Weber, M., Katir, N., Caminade, A., Kadib, A. E., Klajnert‐Maculewicz, B., Majoral, J., & Bryszewska, M. J. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.12.002 · Cited by 24 · see citing works
Tissue-specific toxicity of clothianidin on rainbow trout ( Oncorhynchus mykiss )
Doğan, D., Nur, G., & Deveci, H. A. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.1892128 · Cited by 23 · see citing works
“The clothianidin had no effect on BChE level or the activity in this study, however a scavenger role for chemicals with anticholinesteratic effect (Masson and Lockridge 2010) and functioning as a surrogate for AChE were reported for BChE (Kosak et al.”
BackgroundKašuba, V., Lovaković, B. T., Vrdoljak, A. L., Katić, A., Kopjar, N., Micek, V., Milić, M., Pizent, A., Želježić, D., & Žunec, S. (2022) · Toxics · doi:10.3390/toxics10120717 · Cited by 23 · see citing works
Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxication
Cerasoli, D. M., Armstrong, S. J., Reeves, T. E., Hodgins, S. M., Kasten, S. A., Lee‐Stubbs, R. B., Cadieux, C. L., Otto, T. C., Capacio, B. R., & Lenz, D. E. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113670 · Cited by 23 · see citing works
Thangthaeng, N., Sumien, N., Forster, M. J., Shah, R. A., & Yan, L. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.12.026 · Cited by 23 · see citing works
Maraković, N., Knežević, A., Rončević, I., Brazzolotto, X., Kovarik, Z., & Šinko, G. (2020) · Biochemical Journal · doi:10.1042/bcj20200192 · Cited by 22 · see citing works
Chen, S., Xiang, J., Han, J., Yang‐Feng, Li, H., Chen, H., & Xu, M. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202100443 · Cited by 22 · see citing works
Zhong, G., Guo, J. F., Pang, C., Su, D., Tang, C., Jing, L., Zhang, F., He, P., Yan, Y., Chen, Z., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106224 · Cited by 22 · see citing works
Ali, S. B., Mohamed, A. S., Fahmy, S. R., Garhy, M. E., Mousa, M. R., & Abdel‐Ghaffar, F. (2023) · Acta Parasitologica · doi:10.1007/s11686-023-00728-4 · Cited by 20 · see citing works
“It hydrolyzes ester-containing compounds and acts as a scavenger against neurotoxic organophosphates (OPs) [48].”
BackgroundNon-conventional compounds with potential therapeutic effects against Alzheimer’s disease
de Castro, A. A., Soares, F. V., Pereira, A. F., Polisel, D. A., Caetano, M. S., Leal, D. H. S., da Cunha, E. F. F., Nepovimová, E., Kuča, K., & Ramalho, T. C. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1608823 · Cited by 20 · see citing works
“BuChE is synthesized in the liver, but it is mainly found in blood plasma [186,187], grouped into four major forms depending on the number of molecular subunits.”
BackgroundTheoretical and Practical Aspects of Albumin Esterase Activity
Belinskaia, D. A., & Goncharov, N. V. (2020) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162020030036 · Cited by 20 · see citing works
Atsmon, J., Brill‐Almon, E., Nadri-Shay, C., Chertkoff, R., Alon, S., Shaikevich, D., Volokhov, I., Haim, K. Y., Bartfeld, D., Shulman, A., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.06.004 · Cited by 20 · see citing works
Pulkrabkova, L., Múčková, Ľ., Hrabinová, M., Sorf, A., Kobrlová, T., Jošt, P., Bezděková, D., Korábečný, J., Jun, D., & Soukup, O. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03525-0 · Cited by 19 · see citing works
“The uniformity of the protein load in all samples was verified by the detection of β-tubulin (color figure online) 1 3 acetylthiocholine cleavage (AChE substrate) (Masson and Lockridge 2010).”
MethodEnergy Landscapes of Human Acetylcholinesterase and Its Huperzine A-Inhibited Counterpart
Trapp, M., Trovaslet, M., Nachon, F., Koza, M. M., van Eijck, L., Hill, F. R., Weik, M., Masson, P., Tehei, M., & Peters, J. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp304704h · Cited by 19 · see citing works
Activity and molecular dynamics relationship within the family of human cholinesterases
Peters, J., Trovaslet, M., Trapp, M., Nachon, F., Hill, F. R., Royer, E., Gabel, F., van Eijck, L., Masson, P., & Tehei, M. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp23817a · Cited by 19 · see citing works
New therapeutic approaches and novel alternatives for organophosphate toxicity
Katz, F. S., Pecic, S., Schneider, L., Zhu, Z., Hastings-Robinson, A., Luzac, M., Macdonald, J., Landry, D. W., & Stojanović, M. N. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.03.028 · Cited by 18 · see citing works
Li, H., Wu, C., Zhang, S., Yang, J.-G., Qin, H., & Tang, W. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2103553 · Cited by 18 · see citing works
Lushchekina, S. V., Nemukhin, A. V., Varfolomeev, S. D., & Masson, P. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.04.007 · Cited by 18 · see citing works
“The tetrameric form is the major component of the human plasma BChE [2].”
BackgroundActivity and polymorphisms of butyrylcholinesterase in a Polish population
Jasiecki, J., Jońca, J., Żuk, M., Szczoczarz, A., Janaszak‐Jasiecka, A., Lewandowski, K. K., Waleron, K., & Wasąg, B. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.04.030 · Cited by 17 · see citing works
Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposures
Marsillach, J., Hsieh, E. J., Richter, R. J., MacCoss, M. J., & Furlong, C. E. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.10.019 · Cited by 17 · see citing works
“Furthermore, BChE, as a stoichiometric scavenger, may protect from synthetic and naturally occurring poisons by preventing AChE inhibition by these toxins [13].”
Effects of chlorpyrifos on soil carboxylesterase activity at an aggregate-size scale
Sanchez-Hernandez, J. C., & Sandoval, M. (2017) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2017.04.032 · Cited by 17 · see citing works
Cai, Y., Zhou, S., Stewart, M. J., Zheng, F., & Zhan, C. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108756 · Cited by 16 · see citing works
Petrov, K. A., Iagodina, L. O., Valeeva, G. R., Ивановна, Л. Н., Nikitashina, A. D., Rizvanov, A. A., Васильевич, З. В., Bukharaeva, E. A., Reznik, V. S., Nikolsky, E. E., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01211.x · Cited by 16 · see citing works
“Importantly, addition of horse serum BuChE or recombinant human BuChE into the systemic circulation was able to protect animals from lethal doses of AChE inhibitors (Lenz et al., 2007; Masson and Lockridge, 2010).”
BackgroundPezzementi, L., Nachon, F., & Chatonnet, A. (2011) · PLoS ONE · doi:10.1371/annotation/938a4e59-a5d1-448c-b7c1-632bf9e7e8ef · Cited by 16 · see citing works
Optical imaging probes for selective detection of butyrylcholinesterase
Dirak, M., Chan, J., & Kölemen, S. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02468g · Cited by 15 · see citing works
Sezgin, Z., Biberoğlu, K., Chupakhin, V., Махаева, Г. Ф., & Tacal, Ö. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.01.003 · Cited by 15 · see citing works
- Authors
- Masson, P., & Lockridge, O.
- Affiliations
- University of Nebraska Medical Center (US)
- Venue
- Archives of Biochemistry and Biophysics
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 494
- Issue
- 2
- Pages
- 107-120
- ISSN
- 0003-9861 (ISSN-L)
- PMC
- PMC2819560
- OpenAlex
- W2035067870
- Cited by
- 233
- References
- 174
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 12 · 2023: 6 · 2022: 15 · 2021: 13 · 2020: 14 · 2019: 17 · 2018: 16 · 2017: 17 · 2016: 14 · 2015: 11 · 2014: 11 · 2013: 13 · 2012: 24
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Biochemistry and Biophysics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (U01 NS058056-03)
- NIH Cancer Center (CA036727)
- US Army Medical Research & Materiel Command (W81XWH-07-2-0034)
- French Procurement Agency (DGA/PEA 08co501)
- Agence Nationale pour la Recherche (ANR-06-BLAN-0163)
- Topics
- Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Pesticide Exposure and Toxicity
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Reaction Mechanisms
- Keywords
- butyrylcholinesterase, organophosphate poisoning, enzyme reactivation, oxime reactivation, enzyme inactivation, enzyme kinetics, hysteresis, time delay, enzyme activation, enzyme mutants, acetylcholinesterase
- MeSH terms
- Amino Acid Sequence, Animals, Butyrylcholinesterase, Cholinesterase Inhibitors, Humans, Molecular Sequence Data, Organophosphorus Compounds, Protein Structure, Quaternary, Biocatalysis, Protein Multimerization, Organophosphate Poisoning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review